COVAXIN, India’s COVID Vaccine –
Bharat Biotech, an Indian biotechnology company, is with the National
Institute of Virology to develop an inactivated vaccine candidate for COVID-
19 called Covaxin.
A Phase 1/2 trial of about 1,100 healthy participants
is underway after approval by the Drug Controller General of India.
More with Covaxin, Bharat Biotech is working on two other vaccine
candidates: one with the University of Wisconsin–Madison and FluGen, and
the other with Thomas Jefferson University.
Check Out –
2,537 total views, 2 views today